🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-525125-12-00
Authorised Phase I

A Study to Compare the Blood Levels of Two Dosage Formulations of the Study Medicine in Healthy Adults

2025-525125-12-00 · tracked via the Priya Life Science EU tracker
Sponsor
Pfizer Inc.
Sponsor type
Pharmaceutical company
Therapeutic area
Nervous System Diseases
Decision date
28/04/2026
Enrollment target
36
Sites
Belgium

Condition studied

Migraine with or without aura

Eligibility

Age group
18-64 years, 65+ years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-525125-12-00 on CTIS ↗ ← All trials in the EU